MYAMBUTOL Drug Patent Profile
✉ Email this page to a colleague
When do Myambutol patents expire, and when can generic versions of Myambutol launch?
Myambutol is a drug marketed by Sti Pharma Llc and is included in one NDA.
The generic ingredient in MYAMBUTOL is ethambutol hydrochloride. There are five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethambutol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Myambutol
A generic version of MYAMBUTOL was approved as ethambutol hydrochloride by EPIC PHARMA LLC on November 30th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYAMBUTOL?
- What are the global sales for MYAMBUTOL?
- What is Average Wholesale Price for MYAMBUTOL?
Summary for MYAMBUTOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 9 |
Patent Applications: | 5,239 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MYAMBUTOL |
What excipients (inactive ingredients) are in MYAMBUTOL? | MYAMBUTOL excipients list |
DailyMed Link: | MYAMBUTOL at DailyMed |
![MYAMBUTOL drug patent expirations Drug patent expirations by year for MYAMBUTOL](/p/graph/s/t/MYAMBUTOL-patent-expirations.png)
![Drug Prices for MYAMBUTOL](/p/graph/drug-price/MYAMBUTOL.png)
Recent Clinical Trials for MYAMBUTOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Cape Town | Phase 2 |
Aurum Institute | Phase 2 |
Singapore Immunology Network | Phase 2 |
Pharmacology for MYAMBUTOL
Drug Class | Antimycobacterial |
US Patents and Regulatory Information for MYAMBUTOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sti Pharma Llc | MYAMBUTOL | ethambutol hydrochloride | TABLET;ORAL | 016320-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sti Pharma Llc | MYAMBUTOL | ethambutol hydrochloride | TABLET;ORAL | 016320-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sti Pharma Llc | MYAMBUTOL | ethambutol hydrochloride | TABLET;ORAL | 016320-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sti Pharma Llc | MYAMBUTOL | ethambutol hydrochloride | TABLET;ORAL | 016320-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |